GlobalData analyst Christie Wong said Produodopa’s nearest rival at the moment is Britannia Pharmaceuticals’ continuous subcutaneous infusion of apomorphine delivered using the Apo-go pump ...

Q4 2024 Earnings Call Transcript March 12, 2025 Operator: Greetings. And welcome to the KORU Medical Systems’ Fourth Quarter ...

All eyes are on Alnylam as the company awaits entry into the transthyretin amyloid cardiomyopathy market, which currently ...

Today, the majority of this large-volume subcutaneous market is made up ... syringes to load without interrupting their infusion. The pump will also offer enhanced mobility, ease of use, and ...

has become the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations in advanced Parkinson's, delivered via a pump. Questions about the ...

an infusion pump and manual push with a syringe. The belief is that the new self-administered subcutaneous treatment may offer several advantages, including high levels of patient satisfaction ...

Otulfi was approved for both subcutaneous and intravenous formulations which ... In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius ...

The device is based on our proprietary Infusor platform for subcutaneous drug delivery ... it means that they can market the pump only from October 2025, so we will only see revenue contributions ...

1 Since most other palliative medications are weak acids, alkaline medications are often administered via separate pumps and cannulae. Following the withdrawal of ranitidine, we selected subcutaneous ...